The significance of this achievement cannot be overstated, particularly when more than 103,000 individuals are awaiting life-saving transplants in the United States alone, with 88,000 awaiting kidney transplants.
Surgeon Dr Robert Montgomery, the director of the NYU Langone Transplant Institute, confirmed the significance of this feat by stating, "This work demonstrates a pig kidney -- possessing a sole genetic modification and devoid of experimental medications or devices -- can successfully substitute a human kidney's function for a remarkable 32 days, defying rejection."
Dr Montgomery, a pivotal figure in pioneering this procedure, conducted the inaugural pig-to-human kidney transplant involving genetic modifications in September 2021, followed by a similar procedure in November 2021.
The procedure itself encompassed the removal of the patient's native kidneys, followed by the transplantation of a pig kidney that started urine production. Meticulous monitoring showcased optimal levels of creatinine, a metabolic waste product, and most notably, the absence of rejection indications.
No comments:
Write comments